




Searching News Database: dilated cardiomyopathy
HSMN NewsFeed - 18 Jun 2021
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
HSMN NewsFeed - 13 Feb 2018
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
HSMN NewsFeed - 10 Apr 2017
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
HSMN NewsFeed - 16 Jun 2014
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
HSMN NewsFeed - 9 May 2013
Ochsner Medical Center Implants 1st SynCardia Total Artificial Heart in Gulf South Region
Ochsner Medical Center Implants 1st SynCardia Total Artificial Heart in Gulf South Region
HSMN NewsFeed - 30 Jan 2013
MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer
MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer
HSMN NewsFeed - 20 Sep 2012
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
HSMN NewsFeed - 14 Mar 2012
Aastrom Biosciences Appoints Dr. LaVonne Lang as Head of Regulatory Affairs
Aastrom Biosciences Appoints Dr. LaVonne Lang as Head of Regulatory Affairs
HSMN NewsFeed - 28 Mar 2011
Medtronic Announces FDA Approval of Protecta(TM) Implantable Defibrillators That Reduce Inappropriate Shocks
Medtronic Announces FDA Approval of Protecta(TM) Implantable Defibrillators That Reduce Inappropriate Shocks
HSMN NewsFeed - 18 Nov 2010
University Hospital of Nantes Presents 18-Year Experience with SynCardia’s Total Artificial Heart
University Hospital of Nantes Presents 18-Year Experience with SynCardia’s Total Artificial Heart
HSMN NewsFeed - 17 May 2010
First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy
First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy
HSMN NewsFeed - 9 Mar 2010
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
HSMN NewsFeed - 4 May 2009
SCAI Highlights Cardiac Dimensions Inc AMADEUS Study as an Important "Late Breaking" Clinical Trial
SCAI Highlights Cardiac Dimensions Inc AMADEUS Study as an Important "Late Breaking" Clinical Trial
HSMN NewsFeed - 2 Feb 2009
Cardiac Dimensions(R) Inc. Receives CE Mark for CARILLON Mitral Contour System
Cardiac Dimensions(R) Inc. Receives CE Mark for CARILLON Mitral Contour System
HSMN NewsFeed - 18 Dec 2007
Cardiac Dimensions(R) Inc. Announces Closing of $35.5 Million Round of Financing
Cardiac Dimensions(R) Inc. Announces Closing of $35.5 Million Round of Financing
HSMN NewsFeed - 18 Oct 2007
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
HSMN NewsFeed - 27 Jun 2007
First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
HSMN NewsFeed - 7 May 2007
FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
HSMN NewsFeed - 30 Apr 2007
Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
HSMN NewsFeed - 1 Feb 2007
Aastrom Receives Orphan Drug Designation from FDA for Dilated Cardiomyopathy
Aastrom Receives Orphan Drug Designation from FDA for Dilated Cardiomyopathy
Additional items found! 11

Members Archive contains
11 additional stories matching:
dilated cardiomyopathy
(Password required)
dilated cardiomyopathy
(Password required)